ChromoCure, Inc. (KKUR)

Market Cap	15.00K +82.9%
Revenue (ttm)	n/a
Net Income	-147.24K
EPS	-0.00
Shares Out	15.00B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	900,000
Open	0.000001
Previous Close	n/a
Day's Range	0.000001 - 0.000001
52-Week Range	n/a
Beta	16.04
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About ChromoCure

ChromoCure, Inc. develops and provides proprietary cancer detection systems. The company offers Chromosomal Scanner Series 200, a cancer detection system to measure the genomic characteristic found in 100% of all cancers and never found in normal cells. It also applies its science and technology to non-toxic and non-invasive approaches to cancer therapy and cure research. The company was formerly known as Cyberhand Technologies International, Inc. and changed its name to ChromoCure, Inc. in June 2009. ChromoCure, Inc. was incorporated in 2001 a...

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 2001
• Employees: 100
• Stock Exchange: OTCMKTS
• Ticker Symbol: KKUR

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error